MPP Strikes Deal For Long-Acting Injectable HIV Candidate
Monthly Subcutaneous Injection Licensed From University Of Washington Could Replace Daily Pills
The University of Washington has agreed to license an in-development HIV treatment to the Medicines Patent Pool, which takes the form of a monthly subcutaneous injection instead of daily oral treatment.
